Eric D. Shaff, Director of Seres Therapeutics MCRB, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $7,898. The latest trade was on 05/18.

ES

ES

Eric D. Shaff

Director

Company

Seres Therapeutics MCRB

First filing

23/02/07

Trades

56 trades

Buys / sales

0 / 12

12-month net buying

−$7,898

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	05/18	05/19	259 sh	$7.53	$1,950.27	−2.1%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	02/15	02/18	259 sh	$8.47	$2,193.73	−2.2%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/11/15	25/11/18	217 sh	$17.30	$3,754.1	−1.9%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/08/18	25/08/19	217 sh	$16.65	$3,613.05	−2.0%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/05/16	25/05/19	220 sh	$7.28	$1,601.6	−2.1%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/02/18	25/02/19	12,726 sh	$0.81	$10,308.06	−6.2%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/11/18	24/11/19	2,505 sh	$0.54	$1,352.7	−1.4%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/10/28	24/10/29	8,748 sh	$0.69	$6,036.12	−5.0%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/08/16	24/08/19	2,518 sh	$0.84	$2,115.12	−1.7%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/05/15	24/05/17	2,435 sh	$0.94	$2,288.9	−1.7%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/02/16	24/02/16	11,549 sh	$1.08	$12,472.92	−7.9%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	23/10/30	23/10/31	8,552 sh	$1.35	$11,545.2	−6.9%